Looks like twoleggeddawg, winner by a toe, Would have rather worked up to 8.70, than down from an 8.70 bogus open. SWEAR that was MM's telling shorts, see don't cover yet, its not spiking over 8.70, lulling them into a sense of false security, and inviting more for the eventual slaughter,
Sad, ignorant person who is convinced they are THAT important. This is not a board open to all people, all YAHOO users, it is his/her personal toy to destroy, NO ONE else matters. SICK. The type of person who is done in 5 seconds and is convinced their partner had the time of their life. If it was great FOR me, you must have had a great time, So why are you laughing?
I have a theory on why he took a break from buying. Many think it had something to do with the pbth merger, and the legal suit, which may or not be true. Frost has bought up to and through earnings and mergers and announcements, so I doubt that is it. So what is it, WHY?
Frost makes a ton of money weekly, and a large portion of his net worth is tied up in investments. He has been growing his cash horde to make very large opk buys. There are lock up periods from some of the acquisitions about to expire and blocks he might want to absorb. There is also the pbth shares about to convert, which could also create large sell orders that he might also want to grab, rather than having them hit the bid. Has has historically bought 400-600 shares in a month, he will be buying 1-2 million a day if/when these shares are placed in front of him.
Well that is my theory right or wrong, we will see over the next couple weeks.
I have put so many people on ignore I almost put myself on ignore, the board is trash. I almost deleted the link. The problem with that is the MORON wins.
That is the same range of shares I came up with, found it interesting the volume when we hit 10 and the few days after, 37 million in 4 days, I was like, where are all these shares coming from. You are dead on, on the float, unless we both are wrong.
Gst, Frost owns shares three ways, Frost, Frost gamma trust, and LTS, plus all of his options, take ALL those and then figure all the other insiders, direct and indirect, it is well over 50% of all shares, funds own 15%, so that conservatively is 65%
So sr. where from here? I think we stay in this flat range until the market sees reaction to the now long awaited pbth conversion.
Yes you are likely right, but the market is undecided about that opinion. I felt most would have bailed just prior to the merger but I think the fast closing might have caught a few off guard. Those shares, and if there is some selling, IS THE last chance for those looking to cover. I actually expect 4k launch to precede the share release by a day or two, a hunch.
LOL, pages and pages of bumps that no one sees, but yes on having to look for recent posts. GUY is a MORON. I have to update ignore list twice a day, a waste of my time, but then, think about him and his no life job as a robo poster.
I agree on how ridiculous the time frame has become. Someone posted that though the shares have not been delivered that by calling ones broker they could be sold because they are credited. Though I can not vouch for this being a fact, it is only a phone call. Hope the Israeli tax authority is better than the IRS, weeks could turn into years.
I own no shares but do have a gtc buy order in at a lower price. The close today, 1.42 is the lowest close since Aug, 22. 15 trading days. The low today 1.38 is lowest price since 8/22 also. Needs to hold above 1.22 or it could head back to single digits, likely .88 before it closes gap at .70.
If they really were concerned short term about the price they would not have issued millions of options at .07, but instead made those options in the 1.80-2.00 range. Especially since some were exercisable day one rather than having a year or two lock up. I for one DO NOT think insiders should get ANY in the money options, but only deeply out of money, let them earn the basically free cash machine.
outperform to buy. I can only guess the PT was raised from 9.00 to 10 because Analyst Rating Network left the price target out, but have a consensus of 10.00, instead of 9.66. It appears we now have 3 buys, either all at 10, or two 10's and one 9, if Barrington went from outperform to buy without raising price. If so then there is a minor math glitch on PT, either 10 or 9.66.
Well sine others are asking for this info I will push this to the top, might only last until the board bully pushes it back 8 pages, but it is an attempt to help those with questions.
4k launch, or Rolapitant. Revenue next year should be no less than 200m, though yahoo shows 99m/2013 145/2014, both are TOO low. OPKO is not a start up any more, 600 employees, generating over 170K per employee and doubling revenue year over year is a winning formula. With either 4k or citicoline launch, and given one quarter to ramp up sales Opko WILL turn profitable, likely q1, 2014. Turning eps. positive is a big mile stone, and should get the stock moving much higher.
CL, Sometimes when I read some of the posts by shorts I get the impression they have no idea about the company. I get shorting an over bought stock, then covering on a pull back. I get the idea of Figuring Frost might be forced to step down because of age related illness, but THAT is a lame reason to short OPKO, OPKO will be around in some FORM long after FROST and generating billions in sales.
I get the impression these shorts think opko is some start up biotech with three guys with test tubes and white coats, backed by a billionaire who attempts to manipulate the stock by buying shares.
Truth is Frost does have a certain mystic because of his unprecedented success in the pharma industry, he has OPKO to the point where it could run without him, but his share purchases have no affect on the close of day prices. IT DOES eliminate FLOAT, making a squeeze more painful.
What I think shorts and some longs miss is how LARGE opko is getting, 600 employees and hiring every month, over a 100 million in revenue annually is not bad.
Let us look at actual revenue growth.
In 2010 opko generated revenue from optics devices, hence the name, 2010 revenue = 13 million.
by 2011 optics division sold, but revenue more than doubled = 28 million with about half of that from the sale of the optics division.
2012 generic revenue from diagnostics, pharma, minus optics 28 million,
2013 revenue 47 million
2014 the year we are in will be about 110-125,
So in 5 years OPKo has seen revenue roughly double 4 times, 13,26,54,108, I project next year we do no less then a double to 230, and that is before the fun starts.
BY 2016 1 billion is looking REAL possible, share price 30's. So short away. Tempus Fugit.
2014 is the annual report date which is what I was referring to, which is 2013 sales, = 110-125, when they report 2014 sales it will be 2015, note where I state next year sales 230 million. Sorry for confusion, I took those revenue numbers from the annual reports, and I am estimating next years sales based on anticipated events.
OPKO in the most recent slide gives a US market of 300 million, a new refined, lower, more realistic 4k US number, if they capture 1/3 in the US, and 1/3 in the global market, 2014 annual sales could top 300 m, I am using 1/3 US only, NO GLOBAL to arrive at 230M next year revenue. This assumes no Rolapitant milestone payment, and no citicoline, so I am lowballing, which is my nature, and expect the worse hope for the best attitude.
Every long likes to think opk is the next REGN, what is interesting is to look at opk annual sales, sales growth, then look at the regn annual reports, and their sales growth. I am not going to go look right now but regn basically did 48m, 87m, 187m,
380m, 1b, 2b. Opko has a near identical revenue trajectory. 47, 110, 220, ? ?,
LOL, the second ? is 2016, the year I think it all happens, the year we hit that first 1b, we will see. OPKO has three times the share count of regn but apples to apples opko could get to 80 by 2016-2017 IF IF they hit regn numbers and eps.
John, if you did not receiver your forms from your broker how did you manage to get them. Apparently others could use your help in this regard. Appears some still did not get their forms. Thanks.
BIGG, in the latest filing dated 9/11 the current report, they reaffirmed Q4 for release date, the target market at 300 million, which is new to this presentation. My point is they did not just throw the old Jefferies presentation out there, it was recently reworked and dated Sept 13. Not sure why you need the release sooo badly but it appears to be coming. I guess they are backing off the position that 4k will replace psa, an over 1 billion US market. Personally I think they should make the TEST 50 bucks, and become the new psa standard. I am sure they looked at that, they do plan to offer a psa, and that might be the logic, to sell two tests. No way for me to know. Not the way I would market it, but I am not Frost and do not figure to know what he does so I will roll with it.